Back to
Dimensional Fund Advisors LP
CLDX
Showing 6 of 26 quarters
Position history for
Dimensional Fund Advisors LP's holdings in Celldex Therapeutics, Inc.
Yes. Dimensional Fund Advisors holds 1,148,479 shares of CLDX (Celldex Therapeutics), worth $37.2M, as of its Q3 2026 13F filing. It increased the position by 74,494 shares (+6.9%) from Q2 2026. Dimensional Fund Advisors has held CLDX since Q2 2025, across 6 quarterly 13F filings.
Current Value
$37.2M
Current Shares
1.1M
Total Value Change
+$34.3M
Total Shares Change
+1M
Quarter-by-Quarter History